Goldman Sachs’s Armata Pharmaceuticals ARMP Stock Holding History

Goldman Sachs’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$624K	Buy	60,953 +15,790	+35%	+$133K	﹤0.01%	5454
2025 Q4	$284K	Buy	+45,163	New	+$248K	﹤0.01%	5892
2023 Q1	–	Sell	-13,907	Closed	-$17.2K	–	5904
2022 Q4	$17.2K	Buy	+13,907	New	+$36.2K	﹤0.01%	5714
2017 Q1	–	Sell	-112	Closed	-$7K	–	6736
2016 Q4	$7K	Buy	112 +3	+3%	+$373	﹤0.01%	6789
2016 Q3	$23K	Buy	+109	New	+$25.1K	﹤0.01%	6710
2016 Q2	–	Sell	-2,316	Closed	-$1.28M	–	7008
2016 Q1	$1.28M	Buy	+2,316	New	+$1.19M	﹤0.01%	3871

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs's ARMP Position: Q1 2026 in Review

Goldman Sachs increased its Armata Pharmaceuticals (ARMP) stake by 35% in Q1 2026, buying an estimated $133K and bringing the position to 60,953 shares worth $624K. The position accounts for ﹤0.01% of the portfolio, ranked #5454.

Goldman Sachs first reported a position in ARMP in Q1 2016 and has held it in 6 quarters since. The position peaked at $1.28M in Q1 2016. 45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

Goldman Sachs held 60,953 shares of Armata Pharmaceuticals worth $624K as of Q1 2026.
Goldman Sachs bought 15,790 Armata Pharmaceuticals shares in Q1 2026, an estimated $133K.
Armata Pharmaceuticals made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5454 holding.
Goldman Sachs first reported a position in Armata Pharmaceuticals in Q1 2016 and has held it in 6 quarters since.
Goldman Sachs's Armata Pharmaceuticals position peaked at $1.28M in Q1 2016.
45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.